1
|
Yadav RM, Desai SS, Gupta M, Dalvi A, Bargir UA, Jodhawat N, Setia P, Shinde S, Parab A, Gada A, Taur P, Desai M, Madkaikar M. Clinical Utility of Flow-Cytometry for Diagnosis and Genotype Phenotype Correlation in a Cohort of X-linked Agammaglobulinemia Patients. Indian J Pediatr 2024:10.1007/s12098-024-05127-9. [PMID: 38625483 DOI: 10.1007/s12098-024-05127-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/14/2024] [Accepted: 04/01/2024] [Indexed: 04/17/2024]
Affiliation(s)
- Reetika Malik Yadav
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Sneha Sawant Desai
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Maya Gupta
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Aparna Dalvi
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Umair Ahmad Bargir
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Neha Jodhawat
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Priyanka Setia
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Shweta Shinde
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Ankita Parab
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Ashita Gada
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India
| | - Prasad Taur
- Department of Inborn Errors of Immunity, B.J. Wadia Hospital for Children, Mumbai, India
| | - Mukesh Desai
- Department of Inborn Errors of Immunity, B.J. Wadia Hospital for Children, Mumbai, India
| | - Manisha Madkaikar
- Department of Pediatric Immunology and Leucocyte Biology, ICMR-National Institute of Immunohaematology, Mumbai, India.
| |
Collapse
|
2
|
Gaikwad P, Bargir UA, Shinde S, Kini P, Chaurasia R, Yadav U, Dhawale A, George M, Jodhawat N, Setia P, Vedpathak D, Dalvi A, Parab A, Gupta M, Yadav RM, Goriwale M, Vundinti B, Bhat N, Sapra BK, Otiv M, Sharma R, Madkaikar M. A Clinical Conundrum with Diagnostic and Therapeutic Challenge: a Tale of Two Disorders in One Case. J Clin Immunol 2023; 43:1891-1902. [PMID: 37526892 DOI: 10.1007/s10875-023-01553-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2023] [Accepted: 07/13/2023] [Indexed: 08/02/2023]
Abstract
Living organisms are exposed to exogenous and endogenous agents that affect genomic integrity by creating DNA double strand breaks (DSBs). These breaks are repaired by DNA repair proteins to maintain homeostasis. Defects in DNA repair pathways also affect lymphocyte development and maturation, as DSB sites are critical intermediates for rearrangements required for V(D)J recombination. Recent classifications for inborn errors of immunity (IEIs) have listed DNA repair defect genes in a separate group, which suggests the importance of these genes for adaptive and innate immunity. We report an interesting case of a young female (index P1) with mutations in two different genes, DCLRE1C and FANCA, involved in DNA repair pathways. She presented with clinical manifestations attributed to both defects. With the advent of NGS, more than one defect is increasingly identified in patients with IEIs. Familial segregation studies and appropriate functional assays help ascertain the pathogenicity of these mutations and provide appropriate management and genetic counseling.
Collapse
Affiliation(s)
- Pallavi Gaikwad
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Umair Ahmed Bargir
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Shweta Shinde
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Pranoti Kini
- Department of Pediatric Hematology Oncology, Comprehensive Thalassemia Care, PHO and BMT Centre, Borivali, Mumbai, India
| | - Rajesh Chaurasia
- Radiological Physics and Advisory Division, Bhabha Atomic Research Center, Trombay, Mumbai, India
| | - Usha Yadav
- Radiological Physics and Advisory Division, Bhabha Atomic Research Center, Trombay, Mumbai, India
| | - Amruta Dhawale
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Merin George
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Neha Jodhawat
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Priyanka Setia
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Disha Vedpathak
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Aparna Dalvi
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Ankita Parab
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Maya Gupta
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Reetika Malik Yadav
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Mayuri Goriwale
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Baburao Vundinti
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India
| | - Nagesh Bhat
- Radiological Physics and Advisory Division, Bhabha Atomic Research Center, Trombay, Mumbai, India
| | - B K Sapra
- Radiological Physics and Advisory Division, Bhabha Atomic Research Center, Trombay, Mumbai, India
| | - Madhumati Otiv
- Department of Paediatric Intensive Care Unit, KEM Hospital, Pune, India
| | - Ratna Sharma
- Department of Pediatric Hematology Oncology, Comprehensive Thalassemia Care, PHO and BMT Centre, Borivali, Mumbai, India
| | - Manisha Madkaikar
- Indian Council of Medical Research (ICMR) - National Institute of Immunohaematology (NIIH), KEM Hospital, 13th floor New Multistorey Building, Parel Mumbai, Mumbai, India.
| |
Collapse
|
3
|
Jodhawat N, Bargir UA, Setia P, Taur P, Bala N, Madkaikar A, Yadav RM, Dalvi A, Shinde S, Gupta M, Shelar S, Kambli P, Gowri V, Lokeshwar M, Satoskar P, Desai M, Madkaikar M. Normative data for paediatric lymphocyte subsets: A pilot study from western India. Indian J Med Res 2023; 158:161-174. [PMID: 37787259 PMCID: PMC10645029 DOI: 10.4103/ijmr.ijmr_3282_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/09/2021] [Indexed: 10/04/2023] Open
Abstract
Background & objectives Accurate diagnosis of immunodeficiencies requires a critical comparison of values with age-matched controls. In India, the existing reference values for rare lymphocyte subsets are currently not available and we rely on the data originating from other countries for the interpretation of the results. Furthermore, there is limited information on normal variation for these rare-subset parameters in Indian children. So, this study aimed to establish normative values for clinically important lymphocyte subsets in Indian children at different age groups. Methods 148 children aged ≥16 yr were enrolled in this study. The study population included 61 per cent males and 39 per cent females and was divided into the following groups: cord blood (n=18), 0-6 months (n=9), 6-12 months (n=13), 1-2 yr (n=19), 2-5 yr (n=27), 5-10 yr (n=25) and 10-16 yr (n=37). The absolute and relative percentage of lymphocytes, T, B, natural killer cell, along with activated, naïve and memory subsets, was determined by flow cytometry. Results Median values and the 10th and 90th percentiles were obtained for 34 lymphocyte sub-populations. The T and B naïve compartments showed a decreasing trend, whereas memory cells showed an increase with age. The activated T cell subset shows an increasing pattern up to one year and then declines gradually. Double negative T cells are relatively stable. TCRgd+T cell percentage increases with age. Interpretation & conclusions This single-centre pilot study provides preliminary data that justifies the need for future large-scale multi centric studies to generate a reference range for interpreting extended immunophenotyping profiles in the paediatric age group, making it possible for clinicians to assess the immunological status in inborn errors of immunity, infectious and autoimmune diseases.
Collapse
Affiliation(s)
- Neha Jodhawat
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Umair Ahmed Bargir
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Priyanka Setia
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Prasad Taur
- Division of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India
| | - Nidhi Bala
- Department of Obstetrics & Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, Maharashtra, India
| | - Aditi Madkaikar
- Department of Biosciences & Bioengineering, Indian Institute of Technology, Guwahati, Assam, India
| | - Reetika Malik Yadav
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Aparna Dalvi
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Shweta Shinde
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Maya Gupta
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Shraddha Shelar
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Priyanka Kambli
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| | - Vijaya Gowri
- Division of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India
| | - Madhukar Lokeshwar
- Department of Paediatrics, Kashyap Nursing Home, Mumbai, Maharashtra, India
| | - Purnima Satoskar
- Department of Obstetrics & Gynaecology, Nowrosjee Wadia Maternity Hospital, Mumbai, Maharashtra, India
| | - Mukesh Desai
- Division of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, Maharashtra, India
| | - Manisha Madkaikar
- Department of Pediatric Immunology & Leukocyte Biology, Indian Council of Medical Research - National Institute of Immunohaematology, KEM Hospital, Mumbai, Maharashtra, India
| |
Collapse
|
4
|
Shinde S. Evaluation of Effects of Various Alpha and Beta Angulations for T-loop Made of Stainless Steel and Titanium Molybdenum Archwires during Space Closure: Finite Element Method (FEM) Study. Mymensingh Med J 2023; 32:855-861. [PMID: 37391985] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/02/2023]
Abstract
Space closure follows the initial stage of levelling and alignment in Pre-adjusted Edgewise treatment. There are majorly two methods of space closure, Loop mechanics and Sliding mechanics. Loop mechanics or frictionless mechanics is a preferred method because of its potential to produce pre-determined moment-to-force ratios which accurately achieve controlled movement of teeth. The aim of this finite element study was to evaluate the effects of three types of retraction loops with different moment bends (alpha and beta) made of 0.016"×0.022" stainless steel and TMA archwires with Finite Element Analysis. A Finite element model of CAD geometric model of standard MBT prescription (0.018" slot), Stainless Steel and Titanium Molybdenum Alloy (TMA) wire (0.016" × 0.022") and 3 loops (T-loop, Open Vertical and Closed helical loop) were constructed. A solid model of upper jaw with all permanent maxillary teeth except 1st premolar (extraction) with surrounding periodontal ligament and alveolar bone was prepared. Force, moment to force ratio, mesio-distal crown tipping, mesio-distal root tipping and vertical root movement (extrusion) were measured for different alpha and beta bends in anterior and posterior segments respectively. Force values without moment bends was found to be highest in open vertical loop in both anterior (SS- 414gms; TMA- 255gms) and posterior region (SS-540; TMA-370gms) with both SS and TMA wires. Moment to Force ratio (M/F) at both anterior and posterior segment was found to be highest in T-loop followed by closed helical loop and least in open vertical loop. Extrusion was found to be minimal in T-loop followed by closed helical loop, was maximum in open vertical loop. T-loop showed maximal control in terms of minimal extrusion and maximum M/F ratio amongst the three loops.
Collapse
Affiliation(s)
- S Shinde
- Dr Siddharth Shinde, Assistant Professor, Department of Orthodontics, Bharati Vidyapeeth (Deemed to be University), Dental College & Hospital, Pune, Maharashtra, India; E-mail:
| |
Collapse
|
5
|
Setia P, Bargir UA, Shanmukhaiah C, Jodhawat N, Gaikwad P, Vedpathak D, Dutta S, Kulkarni R, Kambli P, Dalvi A, Shinde S, Gupta M, Nambiar N, Sawant S, Shelar S, Dhawale A, Mohanty M, Yadav RM, Bose K, Madkaikar M. Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas-mediated apoptotic pathway. Br J Haematol 2023. [PMID: 37199216 DOI: 10.1111/bjh.18871] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/18/2023] [Revised: 04/25/2023] [Accepted: 05/06/2023] [Indexed: 05/19/2023]
Affiliation(s)
- Priyanka Setia
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Umair Ahmed Bargir
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | | | - Neha Jodhawat
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Pallavi Gaikwad
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Disha Vedpathak
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Shubhankar Dutta
- Integrated Biophysics and Structural Biology Lab, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre (ACTREC), Navi Mumbai, India
| | - Rucha Kulkarni
- Integrated Biophysics and Structural Biology Lab, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre (ACTREC), Navi Mumbai, India
- Homi Bhabha National Institute (HBNI), BARC Training School Complex, Mumbai, India
| | - Priyanka Kambli
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Aparna Dalvi
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Shweta Shinde
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Maya Gupta
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Nayana Nambiar
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Sneha Sawant
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Shraddha Shelar
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Amruta Dhawale
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Madhu Mohanty
- ICMR-NIV Mumbai unit (ERC), Haffkine Institute Compound, Mumbai, India
| | - Reetika Malik Yadav
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| | - Kakoli Bose
- Integrated Biophysics and Structural Biology Lab, Advanced Centre for Treatment Research and Education in Cancer, Tata Memorial Centre (ACTREC), Navi Mumbai, India
- Homi Bhabha National Institute (HBNI), BARC Training School Complex, Mumbai, India
| | - Manisha Madkaikar
- Department of Paediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), Mumbai, India
| |
Collapse
|
6
|
Dighe S, Shinde R, Shinde S, Raghuvanshi P. A case of abdominal angina treated by hybrid surgery. J Postgrad Med 2023:376070. [PMID: 37171414 PMCID: PMC10394527 DOI: 10.4103/jpgm.jpgm_497_22] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/13/2023] Open
Affiliation(s)
- S Dighe
- Department of Surgery, DMIMSU, AVBRH Campus Sawangi, Wardha, Maharashtra, India
| | - R Shinde
- Department of Surgery, DMIMSU, AVBRH Campus Sawangi, Wardha, Maharashtra, India
| | - S Shinde
- Department of Pharmacology, DMIMSU, AVBRH Campus Sawangi, Wardha, Maharashtra, India
| | - P Raghuvanshi
- Department of Surgery, DMIMSU, AVBRH Campus Sawangi, Wardha, Maharashtra, India
| |
Collapse
|
7
|
Gowri V, Chougule A, Gupta M, Taur P, Iyengar VV, Sivasankaran M, Munirathnam D, Krishna S, Bargir UA, Dalvi A, Setia P, Jodhawat N, Shinde S, Prabhu SS, Bodhanwala M, Madkaikar MR, Desai MM. Clinical, immunological and molecular findings of patients with DOCK-8 deficiency from India. Scand J Immunol 2023:e13276. [PMID: 37114940 DOI: 10.1111/sji.13276] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/19/2022] [Revised: 04/08/2023] [Accepted: 04/25/2023] [Indexed: 04/29/2023]
Abstract
DOCK8 deficiency affects various cell subsets belonging to both innate and adaptive immune systems. Clinical diagnosis is challenging as many cases present with severe atopic dermatitis as the only initial manifestation. Though flow cytometry helps in presumptive diagnosis of DOCK8 deficient patients by evaluating their DOCK8 protein expression, it requires subsequent confirmation by molecular genetic analysis. Currently, hematopoietic stem cell transplantation (HSCT) is the only curative treatment option available for these patients. There is paucity of data from India on clinical diversity and molecular spectrum of DOCK8 deficiency. In the present study we report the clinical, immunological and molecular findings in 17 DOCK8-deficient patients from India diagnosed over last 5 years.
Collapse
Affiliation(s)
- Vijaya Gowri
- Bai Jerbai Wadia Hospital for Children, Parel, Mumbai
| | | | - Maya Gupta
- ICMR- National Institute of Immunohematology, Parel, Mumbai
| | - Prasad Taur
- Bai Jerbai Wadia Hospital for Children, Parel, Mumbai
| | | | | | | | | | - Umair A Bargir
- ICMR- National Institute of Immunohematology, Parel, Mumbai
| | - Aparna Dalvi
- ICMR- National Institute of Immunohematology, Parel, Mumbai
| | - Priyanka Setia
- ICMR- National Institute of Immunohematology, Parel, Mumbai
| | - Neha Jodhawat
- ICMR- National Institute of Immunohematology, Parel, Mumbai
| | - Shweta Shinde
- ICMR- National Institute of Immunohematology, Parel, Mumbai
| | | | | | | | | |
Collapse
|
8
|
Shinde S, Cianfaglione R, Stuart B, Evans H, Hill C. Obstructive sleep apnea in Down syndrome: a meta-analysis and narrative review of surgical and non-surgical treatment outcomes. Sleep Med 2022. [DOI: 10.1016/j.sleep.2022.05.540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
9
|
Yadav RM, Jodhawat N, Gupta M, Dalvi A, Bargir UA, Hule G, Setia P, Shinde S, Saxena S, Parab A, Gada A, Kambli P, Dhawale A, Gaikwad P, Taur P, Chougule A, Iyengar V, Gowri V, Desai M, Madkaikar M. Utility of
HLA‐DR
in screening panel for inborn errors of immunity. Scand J Immunol 2022. [DOI: 10.1111/sji.13238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
Affiliation(s)
- Reetika Malik Yadav
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Neha Jodhawat
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Maya Gupta
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Aparna Dalvi
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Umair Ahmad Bargir
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Gouri Hule
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Priyanka Setia
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Shweta Shinde
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Shilpi Saxena
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Ankita Parab
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Ashita Gada
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Priyanka Kambli
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Amruta Dhawale
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Pallavi Gaikwad
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| | - Prasad Taur
- Department of Inborn errors of Immunity, B.J. Wadia hospital for children Mumbai India
| | - Akshaya Chougule
- Department of Inborn errors of Immunity, B.J. Wadia hospital for children Mumbai India
| | - Vaishnavi Iyengar
- Department of Inborn errors of Immunity, B.J. Wadia hospital for children Mumbai India
| | - Vijaya Gowri
- Department of Inborn errors of Immunity, B.J. Wadia hospital for children Mumbai India
| | - Mukesh Desai
- Department of Inborn errors of Immunity, B.J. Wadia hospital for children Mumbai India
| | - Manisha Madkaikar
- Department of Pediatric Immunology and Leucocyte Biology, ICMR‐National Institute of Immunohaematology Mumbai India
| |
Collapse
|
10
|
Paranna S, Biradar J, Semwal M, Patil K, Suradkar S, Shinde S. Comparative Evaluation of Postoperative Pain in Primary Teeth Obturated With Zinc Oxide Eugenol versus Metapex: A Randomized Clinical Trial. Mymensingh Med J 2022; 31:1148-1152. [PMID: 36189565] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/16/2023]
Abstract
The fundamental objective of pulp treatment is to preserve the integrity and health of oral tissues. Pulp necrosis or irreversible pulpitis is the key indication for performing pulpectomy in primary teeth. It can be performed as a single-visit or multi-visit procedure using suitable obturating material. Various obturating materials can be used like zinc-oxide eugenol or metapex. A controversy reflects in literature and among experts in regard to single-visit or multi-visit endodontics. Hence, the purpose of this randomized clinical trial is to assess the incidence of postoperative pain with zinc oxide eugenol and metapex as an obturating material in single-visit and multiple-visit pulpectomy. The study was conducted at M S Ramaiah Dental College and Hospital, Bangalore in one year duration from 2020 to 2021. Two groups of children, forty in each group, aged between four to eight years, were included in the study. Groups were divided to perform single-visit and multi-visit endodontics with zinc-oxide eugenol and metapex as obturating material. The sample size of 40 were considered and allocated to respective group by concealment allocation. The conventional pulpectomy procedure was carried out. The post operative pain was assessed by using the pain scale through the telephonic conversation with the patient within 24 hours of treatment. Proportions were compared using Chi-square test of significance and the "p" value of less than 0.05 indicates statistical significance. The results showed, no statistically significant difference in teeth obturated with zinc oxide eugenol and metapex in both single-visit and multi-visit pulpectomy. The comparison of zinc oxide eugenol and metapex in single-visit group and multi-visit group had a 'p' value of 0.9233 and 0.4233 respectively. There were no differences between single and multi-visit treatment protocols with respect to the incidence of post operative pain. Single visit pulpectomy can be performed with added advantages with either zinc oxide eugenol or metapex.
Collapse
Affiliation(s)
- S Paranna
- Dr Sujatha Paranna, Associate Professor, Department of Pedodontics and Preventive Dentistry, Bharati Vidyapeeth (Deemed to be University) Dental College and Hospital (BVDUDCH), Sangli, Maharasthra, India; E-mail:
| | | | | | | | | | | |
Collapse
|
11
|
Nimmo AF, Shinde S, Absalom AR. Remifentanil: achieving a 'standard concentration': a reply. Anaesthesia 2022; 77:944. [PMID: 35514203 DOI: 10.1111/anae.15749] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/26/2022] [Indexed: 11/27/2022]
Affiliation(s)
| | | | - A R Absalom
- University of Groningen, Groningen, The Netherlands
| |
Collapse
|
12
|
Cui J, Shinde S, Sen S, Saxena P, Yuan P. Dynamic Binary Translation for SGX Enclaves. ACM Trans Priv Secur 2022. [DOI: 10.1145/3532862] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Abstract
Enclaves, such as those enabled by Intel SGX, offer a hardware primitive for shielding user-level applications from the OS. While enclaves are a useful starting point, code running in the enclave requires additional checks whenever control or data is transferred to/from the untrusted OS. The enclave-OS interface on SGX, however, can be extremely large if we wish to run existing unmodified binaries inside enclaves. This paper presents
Ratel
, a dynamic binary translation engine running inside SGX enclaves on Linux.
Ratel
offers
complete interposition
, the ability to interpose on all executed instructions in the enclave and monitor all interactions with the OS. Instruction-level interposition offers a general foundation for implementing a large variety of inline security monitors in the future.
We take a principled approach in explaining why complete interposition on SGX is challenging. We draw attention to 5 design decisions in SGX that create fundamental trade-offs between performance and ensuring complete interposition, and we explain how to resolve them in the favor of complete interposition. To illustrate the utility of the
Ratel
framework, we present the first attempt to offer
binary compatibility
with existing software on SGX. We report that
Ratel
offers binary compatibility with over 200 programs we tested, including micro-benchmarks and real applications such as Linux shell utilities. Runtimes for two programming languages, namely Python and R, tested with standard benchmarks work out-of-the-box on
Ratel
without any specialized handling.
Collapse
Affiliation(s)
- Jinhua Cui
- National University of Defense Technology, China and National University of Singapore, Singapore
| | | | | | | | | |
Collapse
|
13
|
Kelkar MG, Bargir UA, Malik-Yadav R, Gupta M, Dalvi A, Jodhawat N, Shinde S, Madkaikar MR. CD8 + T Cells Exhibit an Exhausted Phenotype in Hemophagocytic Lymphohistiocytosis. J Clin Immunol 2021; 41:1794-1803. [PMID: 34389889 DOI: 10.1007/s10875-021-01109-0] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2021] [Accepted: 07/22/2021] [Indexed: 12/31/2022]
Abstract
PURPOSE Hemophagocytic lymphohistiocytosis (HLH) is a hyperinflammatory syndrome mainly caused by uncontrolled activation of antigen presenting cells and CD8 T cells. CD8 T cell exhaustion is a known phenomenon in chronic viral infections and cancer. However, the role of T cell exhaustion is not yet identified in HLH in the background of persistent inflammation. So, currently, we have characterized the CD8 T cells using flow cytometry to understand the phenomenon of exhaustion in these cells in HLH. METHODS We have comprehensively evaluated lymphocyte subsets and characterized CD8 T cells using immunophenotypic markers like PD1, TIM3, LAG3, Ki67, Granzyme B, etc. in a cohort of 21 HLH patients. Effector cytokine secretion and degranulation by CD8 T cells are also studied. RESULTS Our findings indicate skewed lymphocyte subsets and aberrantly activated CD8 T cells in HLH. CD8 T cells exhibit significantly increased expression of PD1, TIM3, and LAG3 prominently in primary HLH as compared to controls. PD1 + CD8 T cells express elevated levels of Granzyme B and Ki67. Moreover, CD8 T cells are hypofunctional as evidenced by significantly reduced cytokine secretion and compromised CD107a degranulation. CONCLUSION The study has revealed that CD8 + cytotoxic T lymphocytes from HLH patients exhibited high expression of exhaustion markers with overall impaired function. To the best of our understanding, this is the first report suggesting functional exhaustion of CD8 T cells in both primary and secondary HLH. Future studies to understand the association of exhaustion with disease outcome are needed for its probable therapeutic implementation.
Collapse
Affiliation(s)
- Madhura G Kelkar
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Umair Ahmad Bargir
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Reetika Malik-Yadav
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Maya Gupta
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Aparna Dalvi
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Neha Jodhawat
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Shweta Shinde
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India
| | - Manisha R Madkaikar
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohaematology (NIIH), 13th Floor, NMS Building, KEM Hospital Campus, Parel, , Mumbai, 400012, India.
| |
Collapse
|
14
|
Dwivedi N, Ott AK, Sasikumar K, Dou C, Yeo RJ, Narayanan B, Sassi U, De Fazio D, Soavi G, Dutta T, Balci O, Shinde S, Zhang J, Katiyar AK, Keatley PS, Srivastava AK, Sankaranarayanan SKRS, Ferrari AC, Bhatia CS. Publisher Correction: Graphene overcoats for ultra-high storage density magnetic media. Nat Commun 2021; 12:3437. [PMID: 34078909 PMCID: PMC8172630 DOI: 10.1038/s41467-021-23869-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Affiliation(s)
- N Dwivedi
- CSIR-Advanced Materials and Processes Research Institute, Bhopal, India.,Department of Electrical and Computer Engineering, National University of Singapore, Singapore, Singapore
| | - A K Ott
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK.,Department of Engineering, University of Exeter, Exeter, UK
| | - K Sasikumar
- Center for Nanoscale Materials, Argonne National Laboratory, Argonne, IL, USA
| | - C Dou
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - R J Yeo
- Department of Electrical and Computer Engineering, National University of Singapore, Singapore, Singapore.,Institute of Materials, Ecole Polytechnique Fédérale de Lausanne (EPFL), Lausanne, Switzerland
| | - B Narayanan
- Center for Nanoscale Materials, Argonne National Laboratory, Argonne, IL, USA
| | - U Sassi
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - D De Fazio
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - G Soavi
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - T Dutta
- Department of Electrical and Computer Engineering, National University of Singapore, Singapore, Singapore.,Empa-Swiss Federal Laboratories for Material Science and Technology, Dübendorf, Switzerland
| | - O Balci
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - S Shinde
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - J Zhang
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - A K Katiyar
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK
| | - P S Keatley
- Department of Physics and Astronomy, University of Exeter, Exeter, UK
| | - A K Srivastava
- CSIR-Advanced Materials and Processes Research Institute, Bhopal, India
| | - S K R S Sankaranarayanan
- Center for Nanoscale Materials, Argonne National Laboratory, Argonne, IL, USA.,Department of Mechanical and Industrial Engineering, University of Illinois, Chicago, IL, USA
| | - A C Ferrari
- Cambridge Graphene Centre, University of Cambridge, Cambridge, UK.
| | - C S Bhatia
- Department of Electrical and Computer Engineering, National University of Singapore, Singapore, Singapore
| |
Collapse
|
15
|
Yadav RM, Pate A, Shankarkumar A, Athalye S, Shinde S, Bargir UA, Pate M, Ganpule M, Pruthi M, Patil H, Madkaikar MR. Serosurvey for Health-Care Workers Provides Supportive Evidence for the Effectiveness of Hydroxychloroquine Prophylaxis against SARS-CoV-2 Infection. J Epidemiol Glob Health 2021; 11:283-288. [PMID: 34514761 PMCID: PMC8435873 DOI: 10.2991/jegh.k.210518.001] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2020] [Accepted: 04/15/2021] [Indexed: 01/19/2023] Open
Abstract
Background: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has resulted in occupational exposure among Healthcare Workers (HCWs) and a high risk of nosocomial transmission. Asymptomatic infection and transmission of infection before the development of symptoms are well-recognized factors contributing to the spread of infection. We conducted a cross-sectional observational study to understand the seroprevalence of SARS-CoV-2 infection among HCWs and to verify the appropriateness of infection control measures, particularly Hydroxychloroquine (HCQ) prophylaxis. Methods: A cross-sectional sero-surveillance study was conducted among 500 HCWs in Dombivli and surrounding Mumbai Metropolitan area (Maharashtra, India) between 21st July and 3rd August 2020. The vulnerability of the study participants to SARS-CoV-2 infection was ascertained through a history of (i) involvement in direct care, (ii) exposure to aerosol-generating procedures, (iii) co-morbidities, (iv) Personal Protective Equipment (PPE) use, and (v) HCQ prophylaxis. SARS-CoV-2 IgG antibodies were tested using COVID KAVACH anti-SARS-CoV-2 IgG antibody detection enzyme-linked immunosorbent assay (ELISA) from Zydus Cadila. A systematic analysis of the correlation between the development of antibodies and factors affecting vulnerability to infection was performed. Results: The overall SARS-CoV-2 seroprevalence in the study population was 11%. Providing direct care to COVID-19 patients (Adjusted OR 16.4, 95% CI 3.3–126.9, p = 0.002) for long hours and irregular use of PPE (Adjusted OR 3.78, 95% CI 1.1–11.9, p = 0.02) were associated with an increased incidence of seropositivity. Prophylaxis with HCQ may have a role in reducing the vulnerability to infection as depicted by univariate and multivariate analysis (Adjusted OR 0.55, 95% CI 0.3–0.9, p = 0.047). It was also noted that those not on HCQ prophylaxis were threefold more prone to infection and developed severe disease as compared to those on HCQ prophylaxis. Conclusion: Prophylaxis with HCQ may have a role in mitigating the incidence and severity of SARS-CoV-2 infection. Although vaccination is the most robust strategy to safeguard against COVID-19, it will be months before vaccination percolates to the masses. In the face of the second wave of COVID-19, the use of HCQ prophylaxis in combination with use of face-masks regularly may be considered as a cost-effective measure for population dense areas like urban slums where social distancing is not possible.
Collapse
Affiliation(s)
- Reetika Malik Yadav
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohematology, 13th floor, New Multi-storeyed Building, KEM Hospital Complex, Parel, Mumbai 400012, India
| | - Archana Pate
- Indian Medical Association Dombivli, IMA Hall, 2nd floor, Deepshikha CHS, Dombivli 421201, India
| | - Aruna Shankarkumar
- Department of Transfusion Transmitted Diseases, ICMR-National Institute of Immunohematology, 13th floor, New Multi-storeyed Building, KEM Hospital Complex, Parel, Mumbai 400012, India
| | - Shreyasi Athalye
- Department of Transfusion Transmitted Diseases, ICMR-National Institute of Immunohematology, 13th floor, New Multi-storeyed Building, KEM Hospital Complex, Parel, Mumbai 400012, India
| | - Shweta Shinde
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohematology, 13th floor, New Multi-storeyed Building, KEM Hospital Complex, Parel, Mumbai 400012, India
| | - Umair Ahmed Bargir
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohematology, 13th floor, New Multi-storeyed Building, KEM Hospital Complex, Parel, Mumbai 400012, India
| | - Mangesh Pate
- Indian Medical Association Dombivli, IMA Hall, 2nd floor, Deepshikha CHS, Dombivli 421201, India
| | - Makarand Ganpule
- Indian Medical Association Dombivli, IMA Hall, 2nd floor, Deepshikha CHS, Dombivli 421201, India
| | - Meena Pruthi
- Indian Medical Association Dombivli, IMA Hall, 2nd floor, Deepshikha CHS, Dombivli 421201, India
| | - Hemant Patil
- Indian Medical Association Dombivli, IMA Hall, 2nd floor, Deepshikha CHS, Dombivli 421201, India
| | - Manisha Rajan Madkaikar
- Department of Pediatric Immunology and Leukocyte Biology, ICMR-National Institute of Immunohematology, 13th floor, New Multi-storeyed Building, KEM Hospital Complex, Parel, Mumbai 400012, India
| |
Collapse
|
16
|
Shabrish S, Kelkar M, Yadav RM, Bargir UA, Gupta M, Dalvi A, Aluri J, Kulkarni M, Shinde S, Sawant-Desai S, Kambli P, Hule G, Setia P, Jodhawat N, Gaikwad P, Dhawale A, Nambiar N, Gowri V, Pandrowala A, Taur P, Raj R, Uppuluri R, Sharma R, Kini P, Sivasankaran M, Munirathnam D, Vedam R, Vignesh P, Banday A, Rawat A, Aggarwal A, Poddar U, Girish M, Chaudhary A, Sampagar A, Jayaraman D, Chaudhary N, Shah N, Jijina F, Chandrakla S, Kanakia S, Arora B, Sen S, Lokeshwar M, Desai M, Madkaikar M. The Spectrum of Clinical, Immunological, and Molecular Findings in Familial Hemophagocytic Lymphohistiocytosis: Experience From India. Front Immunol 2021; 12:612583. [PMID: 33746956 PMCID: PMC7973116 DOI: 10.3389/fimmu.2021.612583] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Accepted: 02/04/2021] [Indexed: 11/26/2022] Open
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is a syndrome of immune dysregulation characterized by hyperactivation of the immune system, excessive cytokine secretion and severe systemic inflammation. HLH is classified as familial (FHL) when associated with mutations in PRF1, UNC13D, STX11, and STXBP2 genes. There is limited information available about the clinical and mutational spectrum of FHL patients in Indian population. This study is a retrospective analysis of 101 molecularly characterized FHL patients over the last 10 years from 20 different referral centers in India. FHL2 and FHL3 together accounted for 84% of cases of FHL in our cohort. Patients belonging to different FHL subtypes were indistinguishable based on clinical and biochemical parameters. However, flow cytometry-based assays viz. perforin expression and degranulation assay were found to be specific and sensitive in diagnosis and classification of FHL patients. Molecular characterization of respective genes revealed 76 different disease-causing mutations including 39 (51%) novel mutations in PRF1, UNC13D, STX11, and STXBP2 genes. Overall, survival was poor (28%) irrespective of the age of onset or the type of mutation in our cohort. Altogether, this article sheds light on the current scenario of FHL in India. Our data reveal a wide genetic heterogeneity of FHL in the Indian population and confirms the poor prognosis of FHL. This study also emphasizes that though mutational analysis is important for diagnostic confirmation of FHL, flow cytometry based assays help significantly in rapid diagnosis and functional validation of novel variants identified.
Collapse
Affiliation(s)
- Snehal Shabrish
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Madhura Kelkar
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Reetika Malik Yadav
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Umair Ahmed Bargir
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Maya Gupta
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Aparna Dalvi
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Jahnavi Aluri
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Manasi Kulkarni
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Shweta Shinde
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Sneha Sawant-Desai
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Priyanka Kambli
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Gouri Hule
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Priyanka Setia
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Neha Jodhawat
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Pallavi Gaikwad
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Amruta Dhawale
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Nayana Nambiar
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| | - Vijaya Gowri
- Department of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Ambreen Pandrowala
- Department of Bone Marrow Transplant, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Prasad Taur
- Department of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Revathi Raj
- Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India
| | - Ramya Uppuluri
- Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Chennai, India
| | - Ratna Sharma
- Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & Bone Marrow Transplantation Centre, Mumbai, India
| | - Pranoti Kini
- Comprehensive Thalassemia Care, Pediatric Hematology-Oncology & Bone Marrow Transplantation Centre, Mumbai, India
| | - Meena Sivasankaran
- Department of Pediatric Hemato-Oncology, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India
| | | | - Ramprasad Vedam
- Medgenome Labs Pvt Ltd., Narayana Health City, Bommasandra, India
| | - Pandiarajan Vignesh
- Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Aaqib Banday
- Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Amit Rawat
- Department of Pediatrics, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Amita Aggarwal
- Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
| | - Ujjal Poddar
- Department of Clinical Immunology and Rheumatology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India
| | - Meenakshi Girish
- Department of Pediatrics, All India Institute of Medical Sciences, Nagpur, India
| | - Abhijit Chaudhary
- Department of Pediatrics, All India Institute of Medical Sciences, Nagpur, India
| | | | - Dharani Jayaraman
- Department of Pediatrics, Sri Ramchandra Institute of Higher Education and Research, Chennai, India
| | - Narendra Chaudhary
- Department of Pediatrics, All India Institute of Medical Sciences, Bhopal, India
| | | | | | - S Chandrakla
- Department of Haematology, Seth G. S. Medical College and King Edward Memorial Hospital, Mumbai, India
| | - Swati Kanakia
- Lilavati Hospital and Research Centre, Mumbai, India
| | - Brijesh Arora
- Department of Pediatric Oncology, Tata Memorial Hospital, Mumbai, India
| | - Santanu Sen
- Kokilaben Dhirubai Ambani Hospital, Mumbai, India
| | | | - Mukesh Desai
- Department of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Manisha Madkaikar
- Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research-National Institute of Immunohaematology, Mumbai, India
| |
Collapse
|
17
|
Basade M, Singhal M, Rathi AK, Nandi M, Minhas S, Goswami C, Shinde S, Parikh PM, Aggarwal S. Practical consensus recommendations regarding the management of HER2 neu positive metastatic breast cancer. South Asian J Cancer 2020; 7:146-150. [PMID: 29721483 PMCID: PMC5909294 DOI: 10.4103/sajc.sajc_123_18] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/04/2022] Open
Abstract
Metastatic breast cancer (MBC) is cancer that has spread from the breast to another part of the body or has come back in another distant location. Treatment options for MBC depend on several factors, including where the cancer has spread, the patient's overall health, and the levels of hormone receptors and HER2 in the tumour. Over-expression of HER2 is generally considered to be a negative prognostic feature because it accompanies an increase in breast cancer mortality. However, the development of agents that specifically target HER2 has improved the management of patients with these tumours.[7],[8],[9],[10] This expert group used data from published literature, practical experience and opinion of a large group of academic oncologists to arrive at these practical consensus recommendations in regards with the use of these agents and the management of HER2 positive MBC for the benefit of community oncologists.
Collapse
Affiliation(s)
- M Basade
- Department of Medical Oncology, Saifee Hospital, Mumbai, Maharashtra, India
| | - M Singhal
- Department of Medical Oncology, Indraprastha Apollo Hospital, New Delhi, India
| | - A K Rathi
- Department of Radiation Oncology, MAMC, New Delhi, India
| | - M Nandi
- Department of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India
| | - S Minhas
- Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India
| | - C Goswami
- Department of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India
| | - S Shinde
- Department of Radiation Oncology, Medica Superspecialty Hospital, Kolkata, West Bengal, India
| | - P M Parikh
- Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India
| | - S Aggarwal
- Department of Radiation Oncology, Medica Superspecialty Hospital, Kolkata, West Bengal, India
| |
Collapse
|
18
|
Bhattacharyya GS, Walia M, Nandi M, Murli A, Salim S, Rajpurohit S, Shinde S, Aggarwal S, Parikh PM. Practical consensus recommendations for neo-adjuvant chemotherapy in triple negative breast cancer. South Asian J Cancer 2020; 7:156-158. [PMID: 29721485 PMCID: PMC5909296 DOI: 10.4103/sajc.sajc_126_18] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
Abstract
This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to use neoadjuvant chemotherapy in triple negative breast cancer patients.
Collapse
Affiliation(s)
- G S Bhattacharyya
- Department of Medical Oncology, Fortis Hospital, Kolkata, West Bengal, India
| | - M Walia
- Department of Medical Oncology, Max Hospital, New Delhi, India
| | - M Nandi
- Department of Medical Oncology, Jaypee Hospital, Noida, Uttar Pradesh, India
| | - A Murli
- Department of Medical Oncology, Sarvodaya Hospital, Faridabad, Haryana, India
| | - S Salim
- Department of Oncology, Hakim Sanaullah Cancer Center, Sopore, Jammu and Kashmir, India
| | - S Rajpurohit
- Department of Medical Oncology, RGCI, New Delhi, India
| | - S Shinde
- Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India
| | - S Aggarwal
- Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India
| | - P M Parikh
- Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India
| |
Collapse
|
19
|
Sekhon JS, Naik N, Bansal P, Bansal I, Dhull A, Goel A, Ramachandran CS, Shinde S, Aggarwal S, Parikh PM. Practical consensus recommendations for gestational breast cancer. South Asian J Cancer 2020; 7:115-117. [PMID: 29721476 PMCID: PMC5909287 DOI: 10.4103/sajc.sajc_115_18] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/02/2022] Open
Abstract
This manuscript provides a practical and easy to use consensus recommendation to community oncologists on how to manage gestational breast cancer.
Collapse
Affiliation(s)
- J S Sekhon
- Department of Medical Oncology, Fortis Hospital, Ludhiana, Punjab, India
| | - N Naik
- Department of Surgical Oncology, Dharamshila Cancer Hospital, New Delhi, India
| | - P Bansal
- Department of Medical Oncology, Asian Institute of Medical Sciences, Faridabad, Haryana, India
| | - I Bansal
- Department of Radiation Oncology, Artemis Hospital, Gurugram, Haryana, India
| | - A Dhull
- Department of Radiation Oncology, PGIMS, Rohtak, Haryana, India
| | - A Goel
- Department of Surgical Oncology, Max Hospital, New Delhi, India
| | | | - S Shinde
- Department of Medical Oncology, NCR, New Delhi, India
| | - S Aggarwal
- Department of Medical Oncology, Sir Ganga Ram Hospital, New Delhi, India
| | - P M Parikh
- Department of Oncology, Shalby Cancer and Research Institute, Mumbai, Maharashtra, India
| |
Collapse
|
20
|
Kambli PM, Bargir UA, Yadav RM, Gupta MR, Dalvi AD, Hule G, Kelkar M, Sawant-Desai S, Setia P, Jodhawat N, Nambiar N, Dhawale A, Gaikwad P, Shinde S, Taur P, Gowri V, Pandrowala A, Gupta A, Joshi V, Sharma M, Arora K, Pilania RK, Chaudhary H, Agarwal A, Katiyar S, Bhattad S, Ramprakash S, Cp R, Jayaram A, Gornale V, Raj R, Uppuluri R, Sivasankaran M, Munirathnam D, Lashkari HP, Kalra M, Sachdeva A, Sharma A, Balaji S, Govindraj GM, Karande S, Nanavati R, Manglani M, Subramanyam G, Sampagar A, Ck I, Gutha P, Kanakia S, Mundada SP, Krishna V, Nampoothiri S, Nemani S, Rawat A, Desai M, Madkaikar M. Clinical and Genetic Spectrum of a Large Cohort of Patients With Leukocyte Adhesion Deficiency Type 1 and 3: A Multicentric Study From India. Front Immunol 2020; 11:612703. [PMID: 33391282 PMCID: PMC7772426 DOI: 10.3389/fimmu.2020.612703] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2020] [Accepted: 11/09/2020] [Indexed: 12/11/2022] Open
Abstract
Leukocyte adhesion deficiency (LAD) syndrome is a group of inborn errors of immunity characterized by a defect in the cascade of the activation and adhesion leading to the failure of leukocyte to migrate to the site of tissue injury. Three different types of LAD have been described. The most common subtype is LAD type 1 (LAD1) caused due to defects in the ITGβ2 gene. LAD type 2 (LAD2) is caused by mutations in the SLC35C1 gene leading to a generalized loss of expression of fucosylated glycans on the cell surface and LAD type 3 (LAD3) is caused by mutations in the FERMT3 gene resulting in platelet function defects along with immunodeficiency. There is a paucity of data available from India on LAD syndromes. The present study is a retrospective analysis of patients with LAD collated from 28 different centers across India. For LAD1, the diagnosis was based on clinical features and flow cytometric expression of CD18 on peripheral blood leukocytes and molecular confirmation by Sanger sequencing. For patients with LAD3 diagnosis was largely based on clinical manifestations and identification of the pathogenic mutation in the FERMT3 gene by next-generation Sequencing. Of the total 132 cases diagnosed with LAD, 127 were LAD1 and 5 were LAD3. The majority of our patients (83%) had CD18 expression less than 2% on neutrophils (LAD1°) and presented within the first three months of life with omphalitis, skin and soft tissue infections, delayed umbilical cord detachment, otitis media, and sepsis. The patients with CD18 expression of more than 30% (LAD1+) presented later in life with skin ulcers being the commonest manifestation. Bleeding manifestations were common in patients with LAD3. Persistent neutrophilic leukocytosis was the characteristic finding in all patients. 35 novel mutations were detected in the ITGβ2 gene, and 4 novel mutations were detected in the FERMT3 gene. The study thus presents one of the largest cohorts of patients from India with LAD, focusing on clinical features, immunological characteristics, and molecular spectrum.
Collapse
Affiliation(s)
- Priyanka Madhav Kambli
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Umair Ahmed Bargir
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Reetika Malik Yadav
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Maya Ravishankar Gupta
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Aparna Dhondi Dalvi
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Gouri Hule
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Madhura Kelkar
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Sneha Sawant-Desai
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Priyanka Setia
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Neha Jodhawat
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Nayana Nambiar
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Amruta Dhawale
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Pallavi Gaikwad
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Shweta Shinde
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| | - Prasad Taur
- Department of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Vijaya Gowri
- Department of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Ambreen Pandrowala
- Department of Bone Marrow Transplant, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Anju Gupta
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Vibhu Joshi
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Madhubala Sharma
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Kanika Arora
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Rakesh Kumar Pilania
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Himanshi Chaudhary
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Amita Agarwal
- Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Postgraduate Institute, Lucknow, India
| | - Shobita Katiyar
- Department of Clinical Immunology & Rheumatology, Sanjay Gandhi Postgraduate Institute, Lucknow, India
| | - Sagar Bhattad
- Department of Pediatric Immunology and Rheumatology, Aster CMI Hospital, Bengaluru, India
| | - Stalin Ramprakash
- Pediatric Hemat-Oncology and Bone Marrow Transplant Unit, Aster CMI Hospital, Bengaluru, India
| | - Raghuram Cp
- Pediatric Hemat-Oncology and Bone Marrow Transplant Unit, Aster CMI Hospital, Bengaluru, India
| | - Ananthvikas Jayaram
- Department of Hematology and Pathology, Neuberg Anand Diagnostic and Research Centre, Bangalore, India
| | - Vinod Gornale
- Department of pediatric, Indira Gandhi Institute of Child Health, Bangalore, India
| | - Revathi Raj
- Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Teynampet, India
| | - Ramya Uppuluri
- Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Apollo Hospitals, Teynampet, India
| | - Meena Sivasankaran
- Department of Pediatric, Hemato-oncology, Kanchi Kamakoti Childs Trust Hospital, Chennai, India
| | | | - Harsha Prasad Lashkari
- Department of Paediatrics, Kasturba Medical College, Mangalore, Manipal Academy of Higher Education, Manipal, India
| | - Manas Kalra
- Department of Pediatric Hematology Oncology BMT, Sir Ganga Ram Hospital, New Delhi, India
| | - Anupam Sachdeva
- Department of Pediatric Hematology Oncology BMT, Sir Ganga Ram Hospital, New Delhi, India
| | - Avinash Sharma
- Dr. Rajendra Prasad Government Medical College, Tanda, India
| | - Sarath Balaji
- Department of Paediatrics, Institute of Child Health and Hospital for Children, Chennai, India
| | | | - Sunil Karande
- Department of Pediatrics, King Edward Memorial Hospital, Mumbai, India
| | - Ruchi Nanavati
- Department of Neonatology, King Edward Memorial Hospital, Mumbai, India
| | - Mamta Manglani
- Department of Pediatric, Oncology, Hematology & BMT, Comprehensive Thalassemia Care Center and Bone Marrow, Mumbai, India
| | | | - Abhilasha Sampagar
- Department of Pediatrics, KIES Dr. Prabhakar Kore Hospital & Medical Research, Belgaum, India
| | - Indumathi Ck
- Department of Pediatrics, St. John's Medical College, Bengaluru, India
| | - Parinitha Gutha
- Department of Paediatric Haematology and Oncology, Little Stars Children's Hospital, Hyderabad, India
| | - Swati Kanakia
- Department of Hematology-Oncology, Lilavati Hospital and Research Centre, Mumbai, India
| | | | - Vidya Krishna
- Department of Pediatrics, Sri Ramachandra Medical College, Chennai, India
| | - Sheela Nampoothiri
- Department of Pediatric Genetics, Amrita Institute of Medical Science & Research Center, Cochin, India
| | - Sandeep Nemani
- Nihira Diagnostic Lab, Arihant Galaxy, Ganesh Naga, Sangli, India
| | - Amit Rawat
- Allergy Immunology Unit, Department of Pediatrics, Advanced Pediatrics Centre, Post Graduate Institute of Medical Education and Research, Chandigarh, India
| | - Mukesh Desai
- Department of Immunology, Bai Jerbai Wadia Hospital for Children, Mumbai, India
| | - Manisha Madkaikar
- Center of Excellence for PIDs, Department of Pediatric Immunology and Leukocyte Biology, Indian Council of Medical Research- National Institute of Immunohaematology, Mumbai, India
| |
Collapse
|
21
|
Pignataro D, Foglia F, Della Rocca MT, Melardo C, Santella B, Folliero V, Shinde S, Pafundi PC, Sasso FC, Iovene MR, Galdiero M, Boccia G, Franci G, Finamore E, Galdiero M. Methicillin-resistant Staphylococcus aureus: epidemiology and antimicrobial susceptibility experiences from the University Hospital 'Luigi Vanvitelli' of Naples. Pathog Glob Health 2020; 114:451-456. [PMID: 33012280 DOI: 10.1080/20477724.2020.1827197] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
Abstract
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the important pathogens worldwide showing resistance to several widely used antibiotics. This has made the treatment of MRSA infections harder, especially due to their prevalence in the hospital setting. We evaluated the antibiotic susceptibility patterns of healthcare-associated MRSA infections with a focus on Vancomycin Intermediate S. Aureus (VISA) and macrolide-licosamide-streptogramin B (MLSB) phenotypes. A total of 417 Staphylococcus aureus (S. aureus) cases were isolated between January 2017 and December 2018, through several clinical specimens collected from the University Hospital 'Luigi Vanvitelli' of Naples. We identified bacterial strains using Matrix-Assisted Laser Desorption/Ionization-Time of Flight (MALDI-TOF) and antimicrobial susceptibility using Phoenix BD (Becton Dickinson, NJ, USA). Out of the total 417 S. aureus cases, 140 were MRSA (33.6%) and of these, 50% were soft tissue infections. All MRSA and Methicillin sensible S.aureus MSSA isolates were susceptible to linezolid and daptomycin. Two MRSA cases exhibited intermediate resistance to vancomycin and were of constitutive MLSB phenotype. Among the MRSA strains, 11.4% were constitutive and 43.6% were inducible MLSB phenotypes and 8.6% were macrolide-streptogramin B phenotype. This study characterized the epidemiological status, antibiotic resistance patterns, and current prevalent phenotypes of healthcare-associated MRSA. This knowledge can aid clinicians in improving the antimicrobial stewardship program by adapting appropriate guidelines for the proper use of MRSA antibacterial agents.
Collapse
Affiliation(s)
- D Pignataro
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy
| | - F Foglia
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli" , Naples, Italy
| | - M T Della Rocca
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy
| | - C Melardo
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy
| | - B Santella
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy
| | - V Folliero
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli" , Naples, Italy
| | - S Shinde
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli" , Naples, Italy
| | - P C Pafundi
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli" , Naples, Italy
| | - F C Sasso
- Department of Advanced Medical and Surgical Sciences, University of Campania "Luigi Vanvitelli" , Naples, Italy
| | - M R Iovene
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy
| | - M Galdiero
- Department of Experimental Medicine, University of Campania "Luigi Vanvitelli" , Naples, Italy
| | - G Boccia
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno , Baronissi (SA), Italy
| | - G Franci
- Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", University of Salerno , Baronissi (SA), Italy
| | - E Finamore
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy
| | - M Galdiero
- Section of Microbiology and Virology, University Hospital "Luigi Vanvitelli" of Naples , Naples, Italy.,Department of Experimental Medicine, University of Campania "Luigi Vanvitelli" , Naples, Italy
| |
Collapse
|
22
|
Yentis SM, Shinde S, Bogod D, Flatt N, Hartley H, Keats P, Leifer S, Pappachan J, Parfitt E, Pooni J, Rowland A. Audio/visual recording of doctors in hospitals: Guideline from the Association of Anaesthetists. Anaesthesia 2020; 75:1082-1085. [PMID: 32124425 DOI: 10.1111/anae.15010] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/20/2020] [Indexed: 11/29/2022]
Abstract
Guidelines are presented that summarise the legal position regarding the audio/visual recording of doctors and others in hospitals. In general, there are few, if any, legal grounds for refusing a request by patients to record procedures and/or discussions with clinicians, although some staff may feel uncomfortable being recorded. Trusts and others are advised to draw up local policies and ensure staff and patients are adequately informed.
Collapse
Affiliation(s)
- S M Yentis
- Department of Anaesthesia, Chelsea and Westminster Hospital NHS Foundation Trust, co-Chair, Association of Anaesthetists Working Party, London, UK
| | - S Shinde
- Department of Anaesthesia, Southmead Hospital, North Bristol NHS Trust, Vice-President, Association of Anaesthetists Board of Directors and co-Chair, Association of Anaesthetists Working Party, Bristol, UK
| | - D Bogod
- Department of Anaesthesia, Nottingham University Hospitals NHS Trust, Council member, Royal College of Anaesthetists, Nottingham, UK
| | - N Flatt
- Department of Anaesthesia, Royal Albert Edward Infirmary, Consultants Committee Anaesthetic Specialty Lead, British Medical Association, Wigan, UK
| | - H Hartley
- Medical Protection Society, London, UK
| | - P Keats
- Association of Anaesthetists Board of Directors, London, UK
| | - S Leifer
- Department of Anaesthesia, Lancashire Teaching Hospitals NHS Foundation Trust, Member, Association of Anaesthetists Trainee Committee, Preston, UK
| | - J Pappachan
- Department of Paediatric Intensive Care Medicine, University Hospital Southampton NHS Foundation Trust, Associate Professor, University of Southampton, Council member, Paediatric Intensive Care Society, Southampton, UK
| | - E Parfitt
- Medical and Dental Defence, Union of Scotland, London, UK
| | - J Pooni
- Department of Anaesthesia and Intensive Care, The Royal Wolverhampton NHS Trust, Council member, Intensive Care Society, Wolverhampton, UK
| | - A Rowland
- Business Transformation and Safeguarding for Fitness to Practise, General Medical Council, London, UK
| |
Collapse
|
23
|
Prasad R, Jain NK, Yadav AS, Chauhan DS, Devrukhkar J, Kumawat MK, Shinde S, Gorain M, Thakor AS, Kundu GC, Conde J, Srivastava R. Liposomal nanotheranostics for multimode targeted in vivo bioimaging and near-infrared light mediated cancer therapy. Commun Biol 2020; 3:284. [PMID: 32504032 PMCID: PMC7275035 DOI: 10.1038/s42003-020-1016-z] [Citation(s) in RCA: 23] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/21/2019] [Accepted: 05/07/2020] [Indexed: 02/07/2023] Open
Abstract
Developing a nanotheranostic agent with better image resolution and high accumulation into solid tumor microenvironment is a challenging task. Herein, we established a light mediated phototriggered strategy for enhanced tumor accumulation of nanohybrids. A multifunctional liposome based nanotheranostics loaded with gold nanoparticles (AuNPs) and emissive graphene quantum dots (GQDs) were engineered named as NFGL. Further, doxorubicin hydrochloride was encapsulated in NFGL to exhibit phototriggered chemotherapy and functionalized with folic acid targeting ligands. Encapsulated agents showed imaging bimodality for in vivo tumor diagnosis due to their high contrast and emissive nature. Targeted NFGL nanohybrids demonstrated near infrared light (NIR, 750 nm) mediated tumor reduction because of generated heat and Reactive Oxygen Species (ROS). Moreover, NFGL nanohybrids exhibited remarkable ROS scavenging ability as compared to GQDs loaded liposomes validated by antitumor study. Hence, this approach and engineered system could open new direction for targeted imaging and cancer therapy.
Collapse
Affiliation(s)
- Rajendra Prasad
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India
| | - Nishant K Jain
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India
| | - Amit S Yadav
- Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Center for Cell Science, Pune, 411008, India
- School of Biotechnology and Kalinga Institute of Medical Sciences (KIMS), KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, 751024, India
| | - Deepak S Chauhan
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India
| | - Janhavi Devrukhkar
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India
| | - Mukesh K Kumawat
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India
| | - Shweta Shinde
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India
| | - Mahadeo Gorain
- Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Center for Cell Science, Pune, 411008, India
| | - Avnesh S Thakor
- Interventional Regenerative Medicine and Imaging Laboratory, Department of Radiology, Stanford University, Palo Alto, CA, 94304, USA
| | - Gopal C Kundu
- Laboratory of Tumor Biology, Angiogenesis and Nanomedicine Research, National Center for Cell Science, Pune, 411008, India
- School of Biotechnology and Kalinga Institute of Medical Sciences (KIMS), KIIT Deemed to be University, Institute of Eminence, Bhubaneswar, 751024, India
| | - João Conde
- Centre for Toxicogenomics and Human Health, Genetics, Oncology and Human Toxicology, NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, 1169-056, Lisboa, Portugal.
| | - Rohit Srivastava
- Department of Biosciences and Bioengineering, Indian Institute of Technology Bombay, Powai, Mumbai, Maharashtra, 400076, India.
| |
Collapse
|
24
|
Cook TM, Shinde S. The NAP5 handbook: queries over monitoring neuromuscular function, induction doses, processed EEG monitoring and RSI: a reply. Anaesthesia 2020; 74:1334-1335. [PMID: 31486541 DOI: 10.1111/anae.14805] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
Affiliation(s)
- T M Cook
- Royal United Hospital NHS Trust, Bath, UK
| | | |
Collapse
|
25
|
Nathanson MH, Andrzejowski J, Dinsmore J, Eynon CA, Ferguson K, Hooper T, Kashyap A, Kendall J, McCormack V, Shinde S, Smith A, Thomas E. Guidelines for safe transfer of the brain-injured patient: trauma and stroke, 2019: Guidelines from the Association of Anaesthetists and the Neuro Anaesthesia and Critical Care Society. Anaesthesia 2019; 75:234-246. [PMID: 31788789 DOI: 10.1111/anae.14866] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/31/2019] [Indexed: 12/16/2022]
Abstract
The location of care for many brain-injured patients has changed since 2012 following the development of major trauma centres. Advances in management of ischaemic stroke have led to the urgent transfer of many more patients. The basis of care has remained largely unchanged, however, with emphasis on maintaining adequate cerebral perfusion as the key to preventing secondary injury. Organisational aspects and training for transfers are highlighted, and we have included an expanded section on paediatric transfers. We have also provided a table with suggested blood pressure parameters for the common types of brain injury but acknowledge that there is little evidence for many of our recommendations. These guidelines remain a mix of evidence-based and consensus-based statements. We have received assistance from many organisations representing clinicians who care for these patients, and we believe our views represent the best of current thinking and opinion. We encourage departments to review their own practice using our suggestions for audit and quality improvement.
Collapse
Affiliation(s)
- M H Nathanson
- Department of Anaesthesia, Nottingham University Hospitals NHS Trust, Nottingham, UK.,Association of Anaesthetists (Working Party Chair)
| | - J Andrzejowski
- Department of Anaesthesia, Sheffield Teaching Hospitals NHS Trust, Sheffield, UK.,Neuro Anaesthesia and Critical Care Society (NACCS)
| | - J Dinsmore
- Department of Anaesthesia, St George's University Hospital NHS Trust, London, UK.,Royal College of Anaesthetists
| | - C A Eynon
- Department of Intensive Care, University Hospitals Southampton NHS Foundation Trust, Southampton, UK.,Intensive Care Societies of England, Ireland, Scotland and Wales
| | - K Ferguson
- Department of Anaesthesia, Aberdeen Royal Infirmary, Aberdeen.,Association of Anaesthetists
| | - T Hooper
- Department of Intensive Care and Anaesthesia, North Bristol NHS Trust, Bristol, UK.,Defence Medical Services
| | - A Kashyap
- Department of Paediatric Intensive Care, Great North Children's Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle, UK.,Paediatric Intensive Care Society
| | - J Kendall
- Department of Emergency Medicine, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.,Royal College of Emergency Medicine
| | - V McCormack
- Anaesthesia and Intensive Care Medicine, North West Deanery.,Association of Anaesthetists Trainee Committee
| | - S Shinde
- Department of Anaesthesia, Southmead Hospital, North Bristol NHS Trust, Bristol, UK.,Association of Anaesthetists
| | - A Smith
- Department of Anaesthesia, Royal Lancaster Infirmary, Lancaster, UK
| | - E Thomas
- Departments of Anaesthesia and Intensive Care Medicine, University Hospitals Plymouth NHS Trust, UK.,NACCS
| |
Collapse
|
26
|
Shinde S, Yentis SM, Asanati K, Coetzee RH, Cole‐King A, Gerada C, Harding K, Hawton K, Hennessy A, Keats P, Kumar N, McGlennan A, Pappenheim K, Plunkett E, Prior K, Rowland A. Guidelines on suicide amongst anaesthetists 2019. Anaesthesia 2019; 75:96-108. [DOI: 10.1111/anae.14890] [Citation(s) in RCA: 9] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/19/2019] [Indexed: 02/01/2023]
Affiliation(s)
- S. Shinde
- Department of Anaesthesia Southmead Hospital North Bristol NHS Trust Vice‐President, Association of Anaesthetists and Co‐Chair, Association of Anaesthetists Working Party Bristol UK
| | - S. M. Yentis
- Department of Anaesthesia Chelsea and Westminster Hospital NHS Foundation Trust Co‐Chair, Association of Anaesthetists Working Party London UK
| | - K. Asanati
- Occupational Health Services Epsom and St. Helier University Hospitals NHS Trust Honorary Clinical Senior Lecturer, Imperial College London London UK
| | | | - A. Cole‐King
- Department of Liaison Psychiatry Glan Clwyd Hospital Betsi Cadwaladr University Health Board Wales UK
| | | | - K. Harding
- Palliative Care Doctor and part‐time GP Hereford UK
| | - K. Hawton
- Centre for Suicide Research University Department of Psychiatry Warneford Hospital Oxford UK
| | - A. Hennessy
- Department of Anaesthesia Beaumont Hospital Honorary Secretary, College of Anaesthesiologists of Ireland Dublin Ireland
| | - P. Keats
- Association of Anaesthetists London UK
| | - N. Kumar
- Health Education England – North East Newcastle upon Tyne UK
| | - A. McGlennan
- Chase Farm Hospital Royal Free London NHS Foundation Trust London UK
| | | | - E. Plunkett
- Department of Anaesthesia University Hospitals Birmingham UK
| | - K. Prior
- Department of Anaesthesia King's College Hospital Surgeon Commander, Royal Navy; Royal College of Anaesthetists representative, London, UK, London UK
| | - A. Rowland
- Business Transformation and Safeguarding for Fitness to Practise General Medical Council London UK
| |
Collapse
|
27
|
Barden A, Shinde S, Tsai IJ, Croft KD, Beilin LJ, Puddey IB, Mori TA. Effect of weight loss on neutrophil resolvins in the metabolic syndrome. Prostaglandins Leukot Essent Fatty Acids 2019; 148:25-29. [PMID: 31492430 DOI: 10.1016/j.plefa.2019.07.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/14/2019] [Revised: 06/26/2019] [Accepted: 07/02/2019] [Indexed: 12/13/2022]
Abstract
BACKGROUND Non-resolving inflammation associates with obesity and insulin resistance, and may be dependent on the balance of inflammatory substances and specialised pro-resolving mediators of inflammation (SPM) that act to halt the inflammatory response. This controlled trial examined the effect of weight loss on neutrophil synthesis of SPM in volunteers with the metabolic syndrome (MetS). METHODS Volunteers with MetS (n = 42) were matched for age and gender and randomly assigned to a 12-wk weight loss program followed by 4-wk weight stabilization or a 16-wk weight maintenance program. At baseline and 16 weeks, isolated neutrophils were stimulated with calcium ionophore and the released SPM were measured by LC-MS/MS. RESULTS At baseline the SPM resolvin (Rv) E1, 18R-RvE3, RvD2 and Maresin-1 (MaR-1) were detected from stimulated neutrophils. The concentration of released RvE1 was at least 6-fold that of other detected SPM. Weight loss of 4.7 ± 0.8 kg, led to a 2-fold increase in RvE1, P = 0.013, relative to the weight maintenance group. The increase in RvE1 after weight loss was related to, but independent of leukotriene B4. CONCLUSION: Following weight loss, human neutrophils from individuals with the metabolic syndrome are capable of releasing larger amounts of RvE1 upon stimulation.
Collapse
Affiliation(s)
- A Barden
- Medical School, University of Western Australia, Perth, Australia.
| | - S Shinde
- Medical School, University of Western Australia, Perth, Australia
| | - I-J Tsai
- Medical School, University of Western Australia, Perth, Australia
| | - K D Croft
- School of Biomedical Sciences, University of Western Australia, Perth, Australia
| | - L J Beilin
- Medical School, University of Western Australia, Perth, Australia
| | - I B Puddey
- Medical School, University of Western Australia, Perth, Australia
| | - T A Mori
- Medical School, University of Western Australia, Perth, Australia
| |
Collapse
|
28
|
Yentis SM, Shinde S, Plunkett E, Mortimore A. Suicide amongst anaesthetists – an Association of Anaesthetists survey. Anaesthesia 2019; 74:1365-1373. [DOI: 10.1111/anae.14727] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/08/2019] [Indexed: 11/30/2022]
Affiliation(s)
- S. M. Yentis
- Department of Anaesthesia Chelsea and Westminster Hospital LondonUK
- Imperial College LondonUK
| | - S. Shinde
- Department of Anaesthesia Southmead Hospital North Bristol NHS Trust BristolUK
| | - E. Plunkett
- Department of Anaesthesia University Hospitals Birmingham NHS Foundation Trust BirminghamUK
| | | |
Collapse
|
29
|
Nimmo AF, Absalom AR, Cook TM, Mulvey D, Shinde S. Association of Anaesthetists guidelines for the safe practice of total intravenous anaesthesia. A reply. Anaesthesia 2019; 74:677-678. [DOI: 10.1111/anae.14613] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
30
|
Wilson SR, Shinde S, Appleby I, Boscoe M, Conway D, Dryden C, Ferguson K, Gedroyc W, Kinsella SM, Nathanson MH, Thorne J, White M, Wright E. Guidelines for the safe provision of anaesthesia in magnetic resonance units 2019. Anaesthesia 2019; 74:638-650. [DOI: 10.1111/anae.14578] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/12/2018] [Indexed: 01/02/2023]
Affiliation(s)
- S. R. Wilson
- Department of Neuro‐anaesthesia and Neurocritical Care National Hospital for Neurology and Neurosurgery LondonUK and Neuro Anaesthesia and Critical Care Society of Great Britain and Ireland (Co‐Chair)
| | - S. Shinde
- Department of Anaesthesia North Bristol NHS Trust BristolUK and Vice President, Association of Anaesthetists (Co‐Chair)
| | - I. Appleby
- Department of Neuro‐anaesthesia and Neurocritical Care National Hospital for Neurology and Neurosurgery LondonUK and Neuro Anaesthesia and Critical Care Society of Great Britain and Ireland
| | - M. Boscoe
- Royal College of Anaesthetists LondonUK and Society of Anaesthetists in Radiology
| | - D. Conway
- Department of Anaesthesia Chelsea and Westminster Hospital LondonUK and Trainee Committee, Association of Anaesthetists
| | - C. Dryden
- Jackson Rees Department of Paediatric Anaesthesia Alder Hey Children's Hospital LiverpoolUK and Association of Paediatric Anaesthetists of Great Britain and Ireland
| | - K. Ferguson
- Department of Anaesthesia Aberdeen Royal Infirmary Aberdeen UK and Association of Anaesthetists Safety Representative
| | - W. Gedroyc
- Imperial College LondonUK and Royal College of Radiologists
| | - S. M. Kinsella
- Department of Anaesthesia St Michaels Hospital BristolUK and Editor, Anaesthesia
| | - M. H. Nathanson
- Department of Anaesthesia Nottingham University Hospital NottinghamUK and Immediate Past Honorary Secretary, Association of Anaesthetists
| | - J. Thorne
- Department of Neurosurgery Salford Royal Foundation Trust SalfordUK and Society of British Neurological Surgeons
| | | | - E. Wright
- Jackson Rees Department of Paediatric Anaesthesia Alder Hey Children's Hospital Liverpool UK
| |
Collapse
|
31
|
Nimmo AF, Absalom AR, Bagshaw O, Biswas A, Cook TM, Costello A, Grimes S, Mulvey D, Shinde S, Whitehouse T, Wiles MD. Guidelines for the safe practice of total intravenous anaesthesia (TIVA). Anaesthesia 2018; 74:211-224. [DOI: 10.1111/anae.14428] [Citation(s) in RCA: 62] [Impact Index Per Article: 10.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/02/2018] [Indexed: 12/16/2022]
Affiliation(s)
- A. F. Nimmo
- Department of Anaesthesia; Royal Infirmary of Edinburgh; Edinburgh UK; Society for Intravenous Anaesthesia (Co-Chair of the Working party)
| | - A. R. Absalom
- Department of Anesthesiology; University Medical Center Groningen; University of Groningen; Groningen The Netherlands: Society for Intravenous Anaesthesia
| | - O. Bagshaw
- Department of Anaesthesia; Birmingham Women's and Children's NHS Foundation Trust; Birmingham UK; Association of Paediatric Anaesthetists of Great Britain and Ireland
| | - A. Biswas
- Adult/Obstetric Anesthesiology; Sidra Medicine; Qatar Foundation; Doha Qatar; Society for Intravenous Anaesthesia
| | - T. M. Cook
- Department of Anaesthesia and Intensive Care Medicine; Royal United Hospital NHS Foundation Trust; Bath UK; Royal College of Anaesthetists
| | - A. Costello
- Department of Anaesthesia; Milton Keynes University Hospital NHS Foundation Trust; UK; Association of
Anaesthetists Trainee Committee
| | - S. Grimes
- Department of Anaesthesia; Mid Western Regional Hospital; Limerick Ireland; College of
Anaesthesiologists of Ireland
| | - D. Mulvey
- Department of Anaesthesia; Derby Teaching Hospitals NHS Foundation Trust; Derby UK; Society for Intravenous Anaesthesia
| | - S. Shinde
- Department of Anaesthesia; North Bristol NHS Trust; Bristol UK; Association of Anaesthetists (Co-Chair of the Working Party)
| | - T. Whitehouse
- Department of Anaesthesia and Critical Care; University Hospitals Birmingham NHS Foundation Trust; Birmingham UK; Intensive Care Society
| | - M. D. Wiles
- Department of Anaesthesia; Sheffield Teaching Hospitals NHS Foundation Trust; Sheffield UK; Editor, Anaesthesia
| |
Collapse
|
32
|
O'Sullivan CC, Van Houten HK, Sangaralingham L, Leal AD, Shinde S, Liu H, Ettinger D, Loprinzi CL, Ruddy KJ. Abstract P6-11-18: Ten year trends in antiemetic prescribing in cancer patients receiving highly emetogenic chemotherapy (HEC). Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p6-11-18] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: Prevention of chemotherapy-induced nausea and vomiting (CINV) is essential to preserve quality of life in cancer patients receiving highly emetogenic chemotherapy (HEC) such as doxorubicin-cyclophosphamide (AC) or cisplatin. Recently, new drugs (e.g. fosaprepitant and newer neurokinin 1 receptor antagonists [NK1RAs], rolapitant and netupitant) and updated guidelines for antiemetic use (e.g. adding olanzapine) have emerged. However, trends in real world antiemetic use are understudied.
Methods: We performed a retrospective study using the OptumLabs Data Warehouse (OLDW), which includes administrative claims for privately insured and Medicare Advantage enrollees in the U.S. We identified 34,236 patients age 18 years or older treated with either AC or cisplatin between January 2006 and June 2016. Data collected included baseline demographics (age, gender, census region and race), chemotherapy administered, and presence/absence of a central intravenous access device. Trends of anti-emetic use were presented overall and separately for 5-HT receptor antagonists (5HT3RAs) and NK1RAs.
Results: 23,030 patients (67.3%) received an anthracycline-based regimen (AC with or without docetaxel or paclitaxel), and 11,206 (32.7%) patients received cisplatin. Approximately two thirds of patients were female (n= 23,392). Dexamethasone use was stable over the decade (used by 85-90% in all years). Use of 5HT3RAs, primarily palonosetron and ondansetron, occurred in at least 95% of patients in all study years, consistent with guideline recommendations. NK1RAs were underutilized early on compared with guideline recommendations, but use increased to approximately 80% in the most recently evaluated year. Fosaprepitant use rose precipitously starting in 2009, preceding a sharp fall in aprepitant use beginning in 2011. The use of olanzapine, rolapitant and netupitant was minimal throughout the study period.
Conclusions: Dexamethasone and 5-HT3RAs were used in the vast majority of patients receiving HEC, in accordance with guideline recommendations. Less compliance with guidelines was seen with NK1RA use.
Citation Format: O'Sullivan CC, Van Houten HK, Sangaralingham L, Leal AD, Shinde S, Liu H, Ettinger D, Loprinzi CL, Ruddy KJ. Ten year trends in antiemetic prescribing in cancer patients receiving highly emetogenic chemotherapy (HEC) [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P6-11-18.
Collapse
Affiliation(s)
- CC O'Sullivan
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - HK Van Houten
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - L Sangaralingham
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - AD Leal
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - S Shinde
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - H Liu
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - D Ettinger
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - CL Loprinzi
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| | - KJ Ruddy
- Mayo Clinic, Rochester, MN; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD
| |
Collapse
|
33
|
|
34
|
Magnuson AD, Sun T, Yin R, Liu G, Tolba S, Shinde S, Lei XG. 379 Dietary supplementation of microalgal astaxanthin produced dose-dependent enrichments of the phytochemical and elevations of radical absorbance capacity in tissues and eggs of layer hens. J Anim Sci 2017. [DOI: 10.2527/asasann.2017.379] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
35
|
Shinde S, Meller-Herbert O. Biohacking. Anaesthesia 2017; 72:909. [DOI: 10.1111/anae.13952] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
36
|
Srivastava SK, Shinde S, Singh SK, Mehrotra S, Verma MR, Singh AK, Nandi S, Srivastava N, Singh SK, Goswami TK, Bhure SK, Kumar H, Ghosh SK. Antisperm antibodies in repeat-breeding cows: Frequency, detection and validation of threshold levels employing sperm immobilization, sperm agglutination and immunoperoxidase assay. Reprod Domest Anim 2017; 52:195-202. [DOI: 10.1111/rda.12877] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/02/2016] [Accepted: 09/24/2016] [Indexed: 11/30/2022]
Affiliation(s)
- SK Srivastava
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - S Shinde
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - SK Singh
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - S Mehrotra
- AI Laboratory, LPM; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - MR Verma
- Division of LES & IT; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - AK Singh
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - S Nandi
- Centre for Animal Disease Research and Diagnosis; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - N Srivastava
- Quality Control, Semen Freezing Laboratory; ICAR-Central Institute for Research on Cattle; Meerut India
| | - SK Singh
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - TK Goswami
- Immunology Section; Indian Veterinary Research Institute; Izatnagar India
| | - SK Bhure
- Biochemistry and Food Science Sections; Indian Veterinary Research Institute; Izatnagar India
| | - H Kumar
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| | - SK Ghosh
- Division of Animal Reproduction; ICAR-Indian Veterinary Research Institute; Izatnagar India
| |
Collapse
|
37
|
Lockey DJ, Crewdson K, Davies G, Jenkins B, Klein J, Laird C, Mahoney PF, Nolan J, Pountney A, Shinde S, Tighe S, Russell MQ, Price J, Wright C. AAGBI: Safer pre-hospital anaesthesia 2017: Association of Anaesthetists of Great Britain and Ireland. Anaesthesia 2017; 72:379-390. [PMID: 28045209 PMCID: PMC5324693 DOI: 10.1111/anae.13779] [Citation(s) in RCA: 77] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 11/11/2016] [Indexed: 12/19/2022]
Abstract
Pre-hospital emergency anaesthesia with oral tracheal intubation is the technique of choice for trauma patients who cannot maintain their airway or achieve adequate ventilation. It should be carried out as soon as safely possible, and performed to the same standards as in-hospital emergency anaesthesia. It should only be conducted within organisations with comprehensive clinical governance arrangements. Techniques should be straightforward, reproducible, as simple as possible and supported by the use of checklists. Monitoring and equipment should meet in-hospital anaesthesia standards. Practitioners need to be competent in the provision of in-hospital emergency anaesthesia and have supervised pre-hospital experience before carrying out pre-hospital emergency anaesthesia. Training programmes allowing the safe delivery of pre-hospital emergency anaesthesia by non-physicians do not currently exist in the UK. Where pre-hospital emergency anaesthesia skills are not available, oxygenation and ventilation should be maintained with the use of second-generation supraglottic airways in patients without airway reflexes, or basic airway manoeuvres and basic airway adjuncts in patients with intact airway reflexes.
Collapse
Affiliation(s)
- D. J. Lockey
- North Bristol NHS TrustAAGBI Working PartyBristol UniversityBristolUK
| | - K. Crewdson
- Anaesthetics and Intensive Care MedicineSevern DeaneryUK
| | - G. Davies
- Royal London Hospital/Royal College of Emergency MedicineLondonUK
| | | | - J. Klein
- Derby Hospitals NHS Foundation TrustFaculty of Pre‐hospital CareRoyal College of Surgeons of EdinburghEdinburghUK
| | - C. Laird
- British Association for Immediate CareAuchterarderPerthshireUK
| | - P. F. Mahoney
- Royal Centre for Defence MedicineImperial CollegeLondonUK
| | - J. Nolan
- Royal United Hospital, BathAnaesthesia and Intensive Care Medicine/Resuscitation Medicine at Bristol UniversityRoyal College of AnaesthetistsBristolUK
| | - A. Pountney
- Mid‐Yorkshire NHS TrustBritish Association for Immediate CareIpswichSuffolkUK
| | - S. Shinde
- North Bristol NHS TrustAAGBI BoardBristolUK
| | - S. Tighe
- Countess of Chester HospitalAAGBI BoardChesterUK
| | - M. Q. Russell
- Kent, Surrey, Sussex Air Ambulance TrustRoyal College of General PractitionersTonbridgeUK
| | - J. Price
- Royal United Hospital BathGroup of Anaesthetists in TrainingAAGBIAvonUK
| | - C. Wright
- St Mary's Major Trauma CentreImperial CollegeMilitary Pre‐hospital Emergency MedicineLondonUK
| |
Collapse
|
38
|
|
39
|
Wei W, Anderson P, Gadkari A, Blackburn S, Moon R, Piercy J, Shinde S, Gomez J, Ghorayeb E. 125 Disagreement between physician- and patient-reported disease severity in adults with a history of moderate-to-severe atopic dermatitis. J Invest Dermatol 2016. [DOI: 10.1016/j.jid.2016.02.152] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
40
|
Klein AA, Arnold P, Bingham RM, Brohi K, Clark R, Collis R, Gill R, McSporran W, Moor P, Rao Baikady R, Richards T, Shinde S, Stanworth S, Walsh TS. AAGBI guidelines: the use of blood components and their alternatives 2016. Anaesthesia 2016; 71:829-42. [PMID: 27062274 DOI: 10.1111/anae.13489] [Citation(s) in RCA: 119] [Impact Index Per Article: 14.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 03/11/2016] [Indexed: 12/13/2022]
Abstract
Blood transfusion can be life-saving. Anaesthetists regularly request and administer blood components to their patients. All anaesthetists must be familiar with indications and appropriate use of blood and blood components and their alternatives, but close liaison with haematology specialists and their local blood sciences laboratory is encouraged. Considerable changes in approaches to optimal use of blood components, together with the use of alternative products, have become apparent over the past decade, leading to a need to update previous guidelines and adapt them for the use of anaesthetists working throughout the hospital system.
Collapse
Affiliation(s)
- A A Klein
- Department of Anaesthesia and Intensive Care, Papworth Hospital, Cambridge, UK
| | - P Arnold
- Department of Paediatric Anaesthesia, Alder Hey Children's Hospital, University of Liverpool, Liverpool, UK
| | - R M Bingham
- Department of Paediatric Anaesthesia, Great Ormond Street Hospital for Children, London, UK
| | - K Brohi
- Centre for Trauma Sciences, Barts Health NHS Trust and Queen Mary University of London, London, UK
| | - R Clark
- Department of Anaesthesia, Glasgow Royal Infirmary, Glasgow, UK
| | - R Collis
- Department of Anaesthesia, University Hospital of Wales, Cardiff, UK
| | - R Gill
- Department of Anaesthesia, University Hospital Southampton, UK
| | | | - P Moor
- Department of Anaesthesia, Derriford Hospital, Plymouth, UK
| | - R Rao Baikady
- Department of Anaesthesia, The Royal Marsden Hospital, London, UK
| | - T Richards
- Division of Surgery and Interventional Science, University College Hospital, London, UK
| | - S Shinde
- Department of Anaesthesia, Southmead Hospital, Bristol, UK
| | - S Stanworth
- Department of Haematology, Oxford Radcliffe Hospitals, Oxford, UK
| | - T S Walsh
- Department of Anaesthetics, Critical Care and Pain Medicine, Edinburgh University, Edinburgh, UK
| |
Collapse
|
41
|
Affiliation(s)
| | | | - P. Clyburn
- AAGBI
- University Hospital of Wales; Cardiff
| |
Collapse
|
42
|
Affiliation(s)
- S. Shinde
- Association of Anaesthetists of Great Britain and Ireland
| |
Collapse
|
43
|
Coelho A, Wolf-Johnston AS, Shinde S, Cruz CD, Cruz F, Avelino A, Birder LA. Urinary bladder inflammation induces changes in urothelial nerve growth factor and TRPV1 channels. Br J Pharmacol 2015; 172:1691-9. [PMID: 25297375 DOI: 10.1111/bph.12958] [Citation(s) in RCA: 29] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2014] [Revised: 09/10/2014] [Accepted: 09/26/2014] [Indexed: 12/18/2022] Open
Abstract
BACKGROUND AND PURPOSE The urinary bladder urothelium expresses various receptors and in response to chemical and mechanical stimuli releases mediators, thereby modulating bladder sensory pathways. Transient receptor potential vanilloid 1 (TRPV1) ion channels and nerve growth factor (NGF) in those cells are implicated in this modulatory effect and play a role in sensitizing pain-related afferent pathways during inflammation. In this study, we investigated the interaction between NGF and TRPV1 channels in urothelial cells. EXPERIMENTAL APPROACH Urothelial cells from female Sprague-Dawley rat bladders were cultured to quantify membrane expression of TRPV1 channels and capsaicin-induced ATP release in the presence of NGF alone or with TrKA or PI3K inhibitors. Pain scores from rats with cyclophosphamide (CYP)-induced bladder inflammation were assessed after treatment with a TrkA antagonist. Bladders (from control and CYP rats) were collected and analysed for NGF content and TRPV1 channel expression. KEY RESULTS Cultured cells responded to NGF with increased TRPV1 channel expression in the cell membrane and increased release of ATP. Both responses were blocked by either a TrkA antagonist or a PI3K inhibitor. Treatment in vivo with the TrkA antagonist alleviated pain symptoms and reduced CYP-induced NGF overexpression in the mucosa. Furthermore, in urothelial cells from animals with bladder inflammation, expression of TRPV1 channels in the membrane was significantly increased. CONCLUSIONS AND IMPLICATIONS During bladder inflammation, increased production of NGF in urothelial cells induced increased expression and activity of TRPV1 channels in the cell membrane. This effect was primarily mediated by the PI3K pathway.
Collapse
Affiliation(s)
- A Coelho
- Department of Experimental Biology, Faculty of Medicine, University of Porto, Porto, Portugal; Institute for Molecular and Cell Biology (IBMC), University of Porto, Porto, Portugal
| | | | | | | | | | | | | |
Collapse
|
44
|
Shinde S, Wanger T, Novotny P, Grudem M, Jatoi A. Disease-free ovarian cancer patients report severe pain and fatigue over time: prospective quality of life assessment in a consecutive series. EUR J GYNAECOL ONCOL 2015; 36:155-160. [PMID: 26050353] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/04/2023]
Abstract
UNLABELLED objective: Among ovarian cancer patients, cancer treatment is aggressive and yet survival is often so limited; hence, this study sought to measure quality of life with the ultimate goal of identifying ways of improving it over the duration of these patients' lives. MATERIALS AND METHODS The medical records of all ovarian cancer patients who received some/all of their initial chemotherapy at the Mayo Clinic in Rochester, Minnesota from late 2010 through 2012 were reviewed. Patient-reported quality of life was derived from the following ten-point linear analogue scale questions which had been administered to all patients: 1) How would you describe your degree of pain, on average? 2) How would you describe your level of fatigue, on average? 3) How would you describe your overall quality of life? Quality of life data were censored upon cancer recurrence. RESULTS Among 59 eligible patients, the median cumulative interval during which quality of life was serially assessed was 1.15 years (range: three months, 3.2 years). Area under the curve for pain, fatigue, and global quality of life showed no statistically significant differences between patients treated with dose-dense chemotherapy with carboplatin/paclitaxel (n = 10) versus three-week chemotherapy with carboplatin/paclitaxel (n = 36) versus other (n = 13). Although pain, fatigue, and global quality of life improved over time, 35 of 59 (59%) patients reported grade 4 or worse pain during follow up, and 47 of 59 (80%) reported grade 4 or worse fatigue (higher scores denote worse pain or fatigue). After completion of cancer treatment, 30 (51%) described grade 4 or worse pain or fatigue. The most common pain site was the abdomen/pelvis, followed by the back, followed by the hands, feet, fingers, and toes. CONCLUSION In ovarian cancer patients who remain cancer-free, severe pain and fatigue occur years after cancer treatment. Further research should focus on how best to address these symptoms.
Collapse
|
45
|
Kannan V, Bajpai R, Anand V, Deshpande S, Misra BK, Kapadia A, Almel S, Sankhe M, Desai K, Kannan A, Dubey S, Ashok PP, Shinde S. RT-12 * OUTCOMES IN MEDULLOBLASTOMA: SINGLE INSTITUTION CASE SERIES. Neuro Oncol 2014. [DOI: 10.1093/neuonc/nou270.9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
46
|
Yemul-Golhar S, Shinde S, Kelkar K. Anaesthetic management of a rare variety of cardiac myxoma for emergency decompression laminectomy. Southern African Journal of Anaesthesia and Analgesia 2014. [DOI: 10.1080/22201173.2013.10872895] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
Affiliation(s)
- S Yemul-Golhar
- Department of Anaesthesia, BJ Medical College, Pune, India
| | - S Shinde
- Department of Anaesthesia, BJ Medical College, Pune, India
| | - K Kelkar
- Department of Anaesthesia, BJ Medical College, Pune, India
| |
Collapse
|
47
|
Shinde S, Mahmood S, Singh G, Verma MR. Association between the seminal vesicle weight and certain steroids in buffaloes (Bubalus bubalis). Vet World 2014. [DOI: 10.14202/vetworld.2014.21-25] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
|
48
|
Damji O, Roe J, Shinde S, Kotsovsky O, Kirton A. P 174. Effects of paired associative stimulation on developmental motor plasticity in children. Clin Neurophysiol 2013. [DOI: 10.1016/j.clinph.2013.04.251] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
49
|
Affiliation(s)
- S Shinde
- Division of Pediatric Urology, Apollo Centre for Advanced Pediatrics, Indraprastha Apollo Hospitals, Sarita Vihar, New Delhi, India
| | | | | |
Collapse
|
50
|
Morimoto K, Kanda N, Shinde S, Isobe N. Effect of enterotoxigenic Escherichia coli vaccine on innate immune function of bovine mammary gland infused with lipopolysaccharide. J Dairy Sci 2012; 95:5067-5074. [DOI: 10.3168/jds.2012-5498] [Citation(s) in RCA: 11] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/02/2012] [Accepted: 04/30/2012] [Indexed: 11/19/2022]
|